web analytics

WHO announces first prequalification of a tuberculosis diagnostic test

  • WHO
  • décembre 7, 2024

The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra. It is the first test for TB diagnosis and antibiotic susceptibility testing that meets WHO’s prequalification standards.

Tuberculosis is one of the world’s leading infectious disease killers, causing over a million deaths annually and imposing immense socioeconomic burdens, especially in low- and middle-income countries. Accurate and early detection of TB, especially drug-resistant strains, remains a critical and challenging global health priority.

“This first prequalification of a diagnostic test for tuberculosis marks a critical milestone in WHO’s efforts to support countries in scaling up and accelerating access to high-quality TB assays that meet both WHO recommendations and its stringent quality, safety and performance standards,” said Dr Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products. “It underscores the importance of such groundbreaking diagnostic tools in addressing one of the world’s deadliest infectious diseases.”

WHO prequalification of this test is expected to assure quality of diagnostic tests used to improve access to early diagnosis and treatment. It complements WHO’s endorsement approach, which is grounded in emerging evidence, diagnostic accuracy, and patient outcomes alongside considerations for accessibility and equity, with prequalification requirements on quality, safety, and performance.

WHO’s assessment for prequalification is based on information submitted by the manufacturer, Cepheid Inc., and the review by Singapore’s Health Sciences Authority (HSA), the regulatory agency of record for this product.

Designed for use on the GeneXpert® Instrument System, this nucleic acid amplification test (NAAT) Xpert® MTB/RIF Ultra detects the genetic material of Mycobacterium tuberculosis, the bacterium that causes TB, in sputum samples, and provides accurate results within hours. Simultaneously, the test identifies mutations associated with rifampicin resistance, a key indicator of multidrug-resistant TB.

It is intended for patients who screen positive for pulmonary TB and who have either not started anti-tuberculosis treatment or received less than three days of therapy in the past six months.

“High-quality diagnostic tests are the cornerstone of effective TB care and prevention,” said Dr Rogerio Gaspar, WHO Director for Regulation and Prequalification. “Prequalification paves the way for equitable access to cutting-edge technologies, empowering countries to address the dual burden of TB and drug-resistant TB.”

In a joint effort by WHO Global TB Programme and the Department of Regulation and Prequalification to improve access to quality-assured TB tests and expand diagnostic options for countries, WHO is currently assessing seven additional TB tests.

Articles connexes

End of year statement by WHO Director-General
  • décembre 31, 2024

During Christmas week, I was in Yemen on a United Nations mission to negotiate with the country’s de facto authorities for the release of unjustly detained humanitarians working for the…

Lire la suite / Read more

COVID-19 epidemiological update
  • décembre 25, 2024

This is a special edition of the epidemiological update on COVID-19 that gives an overview of the situation since the disease was first reported to WHO nearly five years ago.

Lire la suite / Read more

A l'officiel

Renouvellement du permis d’opération pour les pharmacies privées

  • janvier 6, 2025
Renouvellement du permis d’opération pour les pharmacies privées

La piscine de Mare d’Albert dans un état piteux

  • janvier 4, 2025
La piscine de Mare d’Albert dans un état piteux

[Vidéo News] Message du nouvel an de Navin Ramgoolam

  • janvier 2, 2025
[Vidéo News] Message du nouvel an de Navin Ramgoolam

Tournée Patient Day pour Anil Baichoo

  • décembre 31, 2024
Tournée Patient Day pour Anil Baichoo

La revendication mauricienne est basée sur trois critères

  • décembre 31, 2024
La revendication mauricienne est basée sur trois critères

800 millions de livres sterlings par année

  • décembre 31, 2024
800 millions de livres sterlings par année
Verified by MonsterInsights